• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

磁共振扩散加权成像在鉴别肝血管瘤与其他高血供肝脏病变中的受试者操作特征分析

Receiver operating characteristic analysis of diffusion-weighted magnetic resonance imaging in differentiating hepatic hemangioma from other hypervascular liver lesions.

作者信息

Vossen Josephina A, Buijs Manon, Liapi Eleni, Eng John, Bluemke David A, Kamel Ihab R

机构信息

Russell H. Morgan Department of Radiology and Radiological Sciences, Johns Hopkins Hospital, Baltimore, MD 21287, USA.

出版信息

J Comput Assist Tomogr. 2008 Sep-Oct;32(5):750-6. doi: 10.1097/RCT.0b013e31816a6823.

DOI:10.1097/RCT.0b013e31816a6823
PMID:18830105
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2760589/
Abstract

PURPOSE

To evaluate the role of diffusion-weighted imaging in differentiating between hepatic hemangiomas, both typical and atypical, and other hypervascular liver lesions.

METHODS

Retrospective review of 182 hypervascular liver lesions in 117 patients was performed. Diffusion and contrast-enhanced magnetic resonance imaging were performed using a 1.5-T unit. Imaging protocol consisted of T2-weighted fast spin-echo images, breath-hold diffusion-weighted echo-planar images, and breath-hold unenhanced and contrast-enhanced T1-weighted 3-dimensional fat-suppressed spoiled gradient-echo images in the arterial phase (20 seconds) and portal venous phase (60 seconds). Signal intensity changes and apparent diffusion coefficient (ADC) values were evaluated for all lesions. Unpaired t test was used to compare the mean ADC values for different lesions, and statistical significance was set at P < 0.01. Receiver operating characteristic analysis was used to determine the accuracy of diffusion-weighted imaging in differentiating hemangiomas from other hypervascular liver lesions.

RESULTS

Lesions included typical and atypical hemangioma (n = 38), hepatocellular carcinoma (HCC; n = 58), focal nodular hyperplasia (FNH; n = 22), and neuroendocrine tumor metastasis (NET; n = 64) with a mean tumor size of 5.3 cm. Mean ADC value for hemangioma, HCC, FNH, and NET was 2.29 x 10(-3), 1.55 x 10(-3), 1.65 x 10(-3), and 1.43 x 10(-3) mm2/s, respectively. There was a statistically significant difference in the ADC value of hemangioma compared with that of FNH (P < 0.001), HCC (P < 0.001), and NET (P < 0.001), respectively. The area under the receiver operating characteristic curve was 0.91.

CONCLUSIONS

Diffusion-weighted magnetic resonance imaging and ADC maps can provide rapid quantifiable information to differentiate typical and atypical hemangiomas from other hypervascular liver lesions.

摘要

目的

评估扩散加权成像在鉴别典型和非典型肝血管瘤与其他富血供肝脏病变中的作用。

方法

对117例患者的182个富血供肝脏病变进行回顾性研究。使用1.5-T设备进行扩散加权及对比增强磁共振成像。成像方案包括T2加权快速自旋回波图像、屏气扩散加权回波平面图像以及屏气未增强和对比增强的T1加权三维脂肪抑制扰相梯度回波图像,分别采集动脉期(20秒)和门静脉期(60秒)图像。评估所有病变的信号强度变化及表观扩散系数(ADC)值。采用非配对t检验比较不同病变的平均ADC值,设定统计学显著性水平为P < 0.01。使用受试者操作特征分析确定扩散加权成像在鉴别血管瘤与其他富血供肝脏病变中的准确性。

结果

病变包括典型和非典型肝血管瘤(n = 38)、肝细胞癌(HCC;n = 58)、局灶性结节性增生(FNH;n = 22)以及神经内分泌肿瘤转移灶(NET;n = 64),平均肿瘤大小为5.3 cm。肝血管瘤、HCC、FNH和NET的平均ADC值分别为2.29×10⁻³、1.55×10⁻³、1.65×10⁻³和1.43×10⁻³ mm²/s。肝血管瘤的ADC值与FNH(P < 0.001)、HCC(P < 0.001)和NET(P < 0.001)相比,差异均具有统计学意义。受试者操作特征曲线下面积为0.91。

结论

扩散加权磁共振成像及ADC图可提供快速定量信息,以鉴别典型和非典型肝血管瘤与其他富血供肝脏病变。

相似文献

1
Receiver operating characteristic analysis of diffusion-weighted magnetic resonance imaging in differentiating hepatic hemangioma from other hypervascular liver lesions.磁共振扩散加权成像在鉴别肝血管瘤与其他高血供肝脏病变中的受试者操作特征分析
J Comput Assist Tomogr. 2008 Sep-Oct;32(5):750-6. doi: 10.1097/RCT.0b013e31816a6823.
2
Utility of volumetric contrast-enhanced and diffusion-weighted MRI in differentiating between common primary hypervascular liver tumors.体素增强对比磁共振成像和弥散加权成像在鉴别常见原发性富血供肝肿瘤中的应用。
J Magn Reson Imaging. 2018 Oct;48(4):1080-1090. doi: 10.1002/jmri.26032. Epub 2018 Apr 6.
3
Diffusion Kurtosis MR Imaging versus Conventional Diffusion-Weighted Imaging for Distinguishing Hepatocellular Carcinoma from Benign Hepatic Nodules.磁共振扩散峰度成像与常规扩散加权成像鉴别肝细胞癌与良性肝结节的比较
Contrast Media Mol Imaging. 2019 Jul 17;2019:2030147. doi: 10.1155/2019/2030147. eCollection 2019.
4
Diffusion-weighted MR imaging with a single-shot echoplanar sequence: detection and characterization of focal hepatic lesions.采用单次激发回波平面序列的扩散加权磁共振成像:肝脏局灶性病变的检测与特征分析
AJR Am J Roentgenol. 1998 Feb;170(2):397-402. doi: 10.2214/ajr.170.2.9456953.
5
Characterization of focal hepatic lesions with ferumoxides-enhanced MR imaging: utility of T1-weighted spoiled gradient recalled echo images using different echo times.钆喷酸葡胺增强磁共振成像对肝脏局灶性病变的特征性分析:使用不同回波时间的T1加权扰相梯度回波图像的效用
J Magn Reson Imaging. 2002 May;15(5):573-83. doi: 10.1002/jmri.10102.
6
Characterization of focal liver lesions by ADC measurements using a respiratory triggered diffusion-weighted single-shot echo-planar MR imaging technique.使用呼吸触发扩散加权单次激发回波平面磁共振成像技术通过表观扩散系数(ADC)测量对肝脏局灶性病变进行特征描述。
Eur Radiol. 2008 Mar;18(3):477-85. doi: 10.1007/s00330-007-0785-9. Epub 2007 Oct 25.
7
Utility of diffusion-weighted MRI in distinguishing benign and malignant hepatic lesions.弥散加权 MRI 在鉴别良恶性肝病变中的应用。
J Magn Reson Imaging. 2010 Jul;32(1):138-47. doi: 10.1002/jmri.22235.
8
Characterization of Liver Tumors by Diffusion-Weighted Imaging: Comparison of Diagnostic Performance Using the Mean and Minimum Apparent Diffusion Coefficient.通过扩散加权成像对肝脏肿瘤进行特征分析:使用平均表观扩散系数和最小表观扩散系数的诊断性能比较
J Comput Assist Tomogr. 2015 Jul-Aug;39(4):453-61. doi: 10.1097/RCT.0000000000000228.
9
Accuracy of visual analysis vs. apparent diffusion coefficient quantification in differentiating solid benign and malignant focal liver lesions with diffusion-weighted imaging.视觉分析与表观扩散系数定量在鉴别扩散加权成像中肝脏局灶性良恶性病变的准确性。
Radiol Med. 2013 Apr;118(3):343-55. doi: 10.1007/s11547-012-0873-z. Epub 2012 Sep 17.
10
Characterization of hepatocellular tumors: value of mangafodipir-enhanced magnetic resonance imaging.肝细胞肿瘤的特征:锰福地匹三钠增强磁共振成像的价值
J Comput Assist Tomogr. 2005 Mar-Apr;29(2):181-90. doi: 10.1097/01.rct.0000156397.51640.a1.

引用本文的文献

1
Hepatic anastomosing hemangioma: description of a rare case and a literature analysis.肝吻合性血管瘤:1例罕见病例描述及文献分析
Quant Imaging Med Surg. 2023 Sep 1;13(9):6355-6362. doi: 10.21037/qims-23-485. Epub 2023 Aug 11.
2
[Application of Diffusion-Weighted Imaging and Hepatobiliary-Specific Contrast Agent Gd-EOB-DTPA in the Diagnosis and Differential Diagnosis of Focal Liver Lesions].扩散加权成像及肝胆特异性对比剂钆塞酸二钠在肝脏局灶性病变诊断及鉴别诊断中的应用
Sichuan Da Xue Xue Bao Yi Xue Ban. 2022 Sep;53(5):737-743. doi: 10.12182/20220960205.
3
Apparent Diffusion Coefficient Can Predict Therapy Response of Hepatocellular Carcinoma to Transcatheter Arterial Chemoembolization.

本文引用的文献

1
Magnetic resonance imaging findings of atypical focal nodular hyperplasia of the liver.肝脏非典型性局灶性结节性增生的磁共振成像表现
Clin Imaging. 2007 Jul-Aug;31(4):244-52. doi: 10.1016/j.clinimag.2007.03.003.
2
Hypervascular hepatic focal lesions: spectrum of imaging features.肝脏富血供局灶性病变:影像特征谱
Curr Probl Diagn Radiol. 2007 May-Jun;36(3):107-23. doi: 10.1067/j.cpradiol.2006.12.004.
3
Imaging of liver metastases: MRI.肝转移瘤的影像学检查:磁共振成像(MRI)
表观扩散系数可预测肝细胞癌经导管动脉化疗栓塞治疗的反应。
Dig Dis. 2022;40(5):596-606. doi: 10.1159/000520716. Epub 2021 Nov 8.
4
Hepatic adenomatosis in liver cirrhosis.肝硬化中的肝腺瘤病
Eur J Radiol Open. 2017 Sep 9;4:115-117. doi: 10.1016/j.ejro.2017.08.001. eCollection 2017.
5
[Importance of diffusion imaging in liver metastases].[扩散成像在肝转移瘤中的重要性]
Radiologe. 2017 May;57(5):382-391. doi: 10.1007/s00117-017-0233-z.
6
Imaging approaches to assess the therapeutic response of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): current perspectives and future trends of an exciting field in development.评估胃肠胰神经内分泌肿瘤(GEP-NETs)治疗反应的影像学方法:一个蓬勃发展的令人兴奋领域的当前观点和未来趋势
Cancer Metastasis Rev. 2015 Dec;34(4):823-42. doi: 10.1007/s10555-015-9598-5.
7
Prognostication and response assessment in liver and pancreatic tumors: The new imaging.肝脏和胰腺肿瘤的预后评估与疗效评估:新型影像学检查
World J Gastroenterol. 2015 Jun 14;21(22):6794-808. doi: 10.3748/wjg.v21.i22.6794.
8
MR imaging of primary hepatic neuroendocrine neoplasm and metastatic hepatic neuroendocrine neoplasm: a comparative study.原发性肝神经内分泌肿瘤与转移性肝神经内分泌肿瘤的磁共振成像:一项对比研究。
Radiol Med. 2015 Nov;120(11):1012-20. doi: 10.1007/s11547-015-0544-y. Epub 2015 Apr 24.
9
Lesion discrimination with breath-hold hepatic diffusion-weighted imaging: a meta-analysis.屏气肝脏扩散加权成像的病变鉴别:一项荟萃分析。
World J Gastroenterol. 2015 Feb 7;21(5):1621-7. doi: 10.3748/wjg.v21.i5.1621.
10
Comparison of Dynamic and Liver-Specific Gadoxetic Acid Contrast-Enhanced MRI versus Apparent Diffusion Coefficients.动态对比增强磁共振成像与钆塞酸二钠肝特异性对比剂增强磁共振成像及表观弥散系数的比较
PLoS One. 2013 Jun 21;8(6):e61898. doi: 10.1371/journal.pone.0061898. Print 2013.
Cancer Imaging. 2007;7(1):2-9. doi: 10.1102/1470-7330.2007.0002.
4
CT and MR imaging evaluation of hepatic adenoma.肝腺瘤的CT与磁共振成像评估
J Comput Assist Tomogr. 2006 Sep-Oct;30(5):745-50. doi: 10.1097/01.rct.0000224630.48068.bf.
5
Education and imaging. Hepatobiliary and pancreatic: calcified cavernous hemangiomas in the liver.
J Gastroenterol Hepatol. 2006 Oct;21(10):1626. doi: 10.1111/j.1440-1746.2006.04702.x.
6
Evaluation of hepatic lesions and hepatic parenchyma using diffusion-weighted echo-planar MR with three values of gradient b-factor.使用具有三个梯度b值的扩散加权回波平面磁共振成像评估肝脏病变和肝实质
J Magn Reson Imaging. 2006 Sep;24(3):637-45. doi: 10.1002/jmri.20682.
7
The functional diffusion map: an imaging biomarker for the early prediction of cancer treatment outcome.功能扩散图谱:一种用于早期预测癌症治疗结果的影像生物标志物。
Neoplasia. 2006 Apr;8(4):259-67. doi: 10.1593/neo.05844.
8
Comparison of CT during arterial portography and MR during arterial portography in the detection of liver metastases.动脉性门静脉造影CT与动脉性门静脉造影MR在检测肝转移瘤中的比较。
AJR Am J Roentgenol. 2006 Jun;186(6):1502-11. doi: 10.2214/AJR.05.0879.
9
The role of functional MR imaging in the assessment of tumor response after chemoembolization in patients with hepatocellular carcinoma.功能磁共振成像在评估肝细胞癌患者化疗栓塞术后肿瘤反应中的作用。
J Vasc Interv Radiol. 2006 Mar;17(3):505-12. doi: 10.1097/01.RVI.0000200052.02183.92.
10
Mangafodipir trisodium-enhanced MRI for the detection and characterization of focal hepatic lesions: is delayed imaging useful?锰福地匹三钠增强MRI用于检测和鉴别肝脏局灶性病变:延迟成像是否有用?
J Magn Reson Imaging. 2006 May;23(5):706-11. doi: 10.1002/jmri.20557.